PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.


Abstract

The potential utility of (89)Zr-panitumumab in assessing HER1 status in distant metastases and understanding the variations in antibody uptake at different lesion sites is demonstrated in this study. (89)Zr-panitumumab can play a vital role in patient stratification and immunotherapy and therefore warrants further investigation for clinical translation.


Full Text


Subjects


Similar articles

Authors


Publication date

2012-01-03


Journal

Journal of nuclear medicine
J Nucl Med (1535-5667)

Journal topics


Language

Eng.


Copyright

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. tapann [at] gmail.com


Release reference

J Nucl Med. 2012 Jan;53(1):113-20



Related books


Español | English

© Galenicom 1999-2013